Skip to content

Effect of Monosaccharides on Intestinal Barrier Function

Exploratory Study on the Modulation of Endotoxemia and Metabolic Parameters: Role of Macronutrients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03482284
Acronym
ENDO-META
Enrollment
12
Registered
2018-03-29
Start date
2016-05-20
Completion date
2018-08-01
Last updated
2019-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary Habits, Endotoxemia

Brief summary

The aim of the present study is to determine the effect of monosaccharides on intestinal barrier function in healthy subjects.

Detailed description

In the intervention study normal weight participants will receive defined amounts of monosaccharides for several days. Before and after intervention parameters of intestinal barrier function will be assessed.

Interventions

OTHERDietary Intervention

Participants receive different monosaccharides for a defined number of days.

Sponsors

Prof. Dr. Ina Bergheim
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

All participants receive all interventional diets.

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI \<25 kg/m2 * no kown history of metabolic disorders or fatty liver

Exclusion criteria

* food allergies or intolerances (esp. fructose intolerance and malabsorption) * renal insufficiency * chronic disease of the gastrointestinal tract * taking drugs affecting lipid or glucose metabolism

Design outcomes

Primary

MeasureTime frameDescription
Changes in parameters of intestinal barrier function1 weekChanges in endotoxin plasma levels

Secondary

MeasureTime frameDescription
Changes in blood lipid levels1 weekChanges in triglyceride levels
Changes in Uric Acid levels1 weekChanges in Uric Acid blood levels
Changes in blood pressure1 weekChanges in systolic and diastolic blood pressure
Changes in markers for glucose metabolism1 weekChanges in fasting glucose and fasting insulin levels

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026